Organizations Filed Purposes:
TO SUPPORT CANCER RESEARCH IN ISRAEL, FOR THE BENEFIT OF ISRAEL AND ALL MANKIND.
PROVIDE CANCER RESEARCH FUNDING FOR ISRAELI SCIENTISTS. ICRF IS THE LARGEST NON-PROFIT IN NORTH AMERICA DEDICATED TO SUPPORTING CANCER RESEARCH IN ISRAEL. OVER THE LAST 40 YEARS, ICRF HAS PROVIDED MORE THAN $72 MILLION TO SUPPORT CANCER RESEARCH IN ISRAEL, FUNDING NEARLY 2,500 RESEARCH PROJECTS AT ALL OF THE MAJOR ISRAELI RESEARCH INSTITUTIONS. TYPICALLY, 60-80 GRANTS ARE FUNDED ANNUALLY, BASED ON AN EVALUATION AND PRIORITIZATION BY INDEPENDENT REVIEW PANELS CONSISTING OF 40-50 LEADING CANCER SCIENTISTS FROM NORTH AMERICAN BIOMEDICAL RESEARCH CENTERS. ICRF GRANT CATEGORIES ARE TAILORED TO SUPPORT CANCER RESEARCHERS AT ALL OF THE VARIOUS STAGES OF THEIR CAREERS, AND WE ARE PROUD TO HAVE HELPED SUPPORT MANY OF TODAY'S MOST OUTSTANDING SCIENTISTS AT THE EARLIEST STAGES IN THEIR CAREERS. ICRF SEEKS TO CAPITALIZE ON THE SIGNIFICANTLY LOWER COSTS OF CONDUCTING CANCER RESEARCH IN ISRAEL. ALL AWARDS GO DIRECTLY TO THE DESIGNATED RESEARCHER WITHOUT ANY REDUCTION FOR OVERHEAD.
SUPPORT THE DEVELOPMENT OF THE NEXT GENERATION OF ISRAELI CANCER SCIENTISTS. ICRF IS COMMITTED TO FACILITATING THE DEVELOPMENT OF FUTURE CANCER SCIENTISTS IN ISRAEL. TOWARDS THIS END ICRF FUNDS THREE TYPES OF GRANTS: POSTDOCTORAL FELLOWSHIP AWARDS, RESEARCH CAREER DEVELOPMENT AWARDS, AND CLINICAL RESEARCH CAREER DEVELOPMENT AWARDS. FELLOWSHIPS SUPPORT MDS AND PHDS WHO HAVE JUST COMPLETED THEIR POSTGRADUATE TRAINING. THESE AWARDS CAN BE USED TO SUPPORT SALARIES OR RESEARCH COSTS, WHILE THESE INDIVIDUALS APPRENTICE IN THE LABORATORIES OF SENIOR INVESTIGATORS. CAREER DEVELOPMENT AWARDS ARE TO ENHANCE THE RESEARCH CAPABILITIES OF YOUNG ISRAELI SCIENTISTS IN THE FORMATIVE PHASE OF THEIR CAREERS. CANDIDATES MUST HAVE DEMONSTRATED OUTSTANDING POTENTIAL FOR CONTRIBUTIONS TO CANCER RESEARCH AND MUST EXHIBIT GREAT POTENTIAL TO BECOME INDEPENDENT INVESTIGATORS RESEARCH. SUPPORTING THESE NEWLY LAUNCHED SCIENTISTS, ENHANCES THEIR OPPORTUNITIES IN ISRAEL AND ALLOWS THEM TO OPTIMIZE THEIR WORK WITHOUT EMIGRATING TO OTHER ADVANCED COUNTRIES.
SUPPORT COLLABORATIVE CANCER RESEARCH CONDUCTED BY ISRAELI SCIENTISTS IN ASSOCIATION WITH NORTH AMERICAN CANCER SCIENTISTS. CANCER SCIENCE OFTENTIMES REQUIRES MULTI-DISCIPLINARY APPROACHES, ENGAGEMENT WITH HIGHLY SPECIALIZED AREAS OF SCIENCE, AND EXPENSIVE EQUIPMENT THAT IS NOT EASILY ACCESSED. COLLABORATIONS BETWEEN SCIENTISTS IN ISRAEL AND NORTH AMERICA CAN ADDRESS THESE CHALLENGES, FOSTER UNEXPECTED SYNERGIES, AND ENHANCE BOTH INTELLECTUAL CURIOSITY AND INNOVATION. ICRF PROMOTES COLLABORATION BY SUPPORTING GRANTS THAT FUND PROMISING CANCER RESEARCH PROJECTS BEING CONDUCTED ON A COLLABORATIVE BASIS BETWEEN INVESTIGATORS IN ISRAEL AND AN AMERICAN OR CANADIAN RESEARCH INSTITUTION.
Executives Listed on Filing
Total Salary includes financial earnings, benefits, and all related organization earnings listed on tax filing
| Name | Title | Hours Per Week | Total Salary |
|---|
| Mark A Israel Md | NATL EXECUTIVE DIRECTOR | 40 | $305,915 |
| Allyson Marks-Greenfield | EXECUTIVE DIRECTOR, CHICAGO | 40 | $170,000 |
| Kenneth J Gabel | NY DIRECTOR OF DEVELOPMENT | 40 | $164,227 |
| Caitlin Shmidheiser | CHIEF DEVELOPMENT OFFICER | 40 | $120,000 |
| Dov Zevy | AT-LARGE TRUSTEE | 2 | $0 |
| Sidney J Winawer Md | AT-LARGE TRUSTEE | 2 | $0 |
| Norman Shiner | AT-LARGE TRUSTEE | 2 | $0 |
| Lisa Schoenberg | AT-LARGE TRUSTEE | 2 | $0 |
| Jane Rabhan | AT-LARGE TRUSTEE | 2 | $0 |
| Tom Peled | AT-LARGE TRUSTEE | 2 | $0 |
| Lisa Oved | AT-LARGE TRUSTEE | 2 | $0 |
| Patrick Mundt | AT-LARGE TRUSTEE | 2 | $0 |
| David Malkin Md | AT-LARGE TRUSTEE | 2 | $0 |
| Moni Lustig | AT-LARGE TRUSTEE | 2 | $0 |
| Richard Lipkin | AT-LARGE TRUSTEE | 2 | $0 |
| Barbara Kasell | AT-LARGE TRUSTEE | 2 | $0 |
| Ian Kady | AT-LARGE TRUSTEE | 2 | $0 |
| Clive Kabatznik | AT-LARGE TRUSTEE | 2 | $0 |
| Samuel Herzfeld | AT-LARGE TRUSTEE | 2 | $0 |
| Robert Greene | AT-LARGE TRUSTEE | 2 | $0 |
| Kenneth E Goodman | AT-LARGE TRUSTEE | 2 | $0 |
| Gary I Grad Md | AT-LARGE TRUSTEE | 2 | $0 |
| Tamir Gilat | AT-LARGE TRUSTEE | 2 | $0 |
| S Donald Friedman | AT-LARGE TRUSTEE | 2 | $0 |
| Bonnie E Fish | AT-LARGE TRUSTEE | 2 | $0 |
| Harriet Elisofon | AT-LARGE TRUSTEE | 2 | $0 |
| Steven B Cohen | AT-LARGE TRUSTEE | 2 | $0 |
| Michelle Chrein | AT-LARGE TRUSTEE | 2 | $0 |
| Louis Brause | AT-LARGE TRUSTEE | 2 | $0 |
| Jeffrey Bly | AT-LARGE TRUSTEE | 2 | $0 |
| Arnold M Baskies Md | AT-LARGE TRUSTEE | 2 | $0 |
| Bruce Barron | AT-LARGE TRUSTEE | 2 | $0 |
| Robert Bard | AT-LARGE TRUSTEE | 2 | $0 |
| Yashar Hirshaut Md | EXECUTIVE COMMITTEE MEMBER | 2 | $0 |
| Vera Finkelstein | EXECUTIVE COMMITTEE MEMBER | 2 | $0 |
| Bradley Goldhar | EXECUTIVE COMMITTEE MEMBER | 2 | $0 |
| Benjamin Bonavida Phd | EXECUTIVE COMMITTEE MEMBER | 2 | $0 |
| Cynthia Perl | SECRETARY | 2 | $0 |
| Alan Berk | TREASURER | 2 | $0 |
| Jeffrey Bernstein | VICE PRESIDENT | 2 | $0 |
| Charles Ben Dayan | VICE PRESIDENT | 2 | $0 |
| David Abramson | VICE PRESIDENT | 2 | $0 |
| Peter J Stambrook Phd | VICE-CHAIRMAN | 2 | $0 |
| Joel N Pelofsky | FIRST VICE-PRESIDENT | 2 | $0 |
| Bryna Goldberg | CHAIRMAN | 2 | $0 |
| Robert Densen | PRESIDENT | 2 | $0 |
Data for this page was sourced from XML published by IRS (
public 990 form dataset) from:
https://s3.amazonaws.com/irs-form-990/202013099349302411_public.xml